Stryker Neurovascular: FDA filings under this applicant name
FDA lists 34 510(k) clearances under the applicant name “Stryker Neurovascular” (first 2011, latest 2026), plus 2 PMA decisions, across 9 product codes in 2 review panels. Median 510(k) review time under this name: 105 days. Since 2017 the median was 123 days, against 118 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Stryker, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 3 | 29 |
| 2013 | 2 | 118 |
| 2014 | 1 | 63 |
| 2015 | 0 | — |
| 2016 | 3 | 31 |
| 2017 | 1 | 249 |
| 2018 | 0 | — |
| 2019 | 4 | 54 |
| 2020 | 3 | 30 |
| 2021 | 4 | 186 |
| 2022 | 1 | 114 |
| 2023 | 1 | 153 |
| 2024 | 2 | 188 |
| 2025 | 4 | 115 |
| 2026 | 3 | 142 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Stryker Neurovascular took a median 123 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 118 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| HCG | Device, Neurovascular Embolization | 11 | 11 |
| QJP | Catheter, Percutaneous, Neurovasculature | 10 | 10 |
| DQY | Catheter, Percutaneous | 6 | 6 |
| POL | Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment | 3 | 3 |
| NRY | Catheter, Thrombus Retriever | 2 | 2 |
| MJN | Catheter, Intravascular Occluding, Temporary | 1 | 1 |
| MOF | Guide, Wire, Catheter, Neurovasculature | 1 | 1 |
| OUT | Intracranial Aneurysm Flow Diverter | 1 | 0 |
| QCA | Intracranial Coil-Assist Stent | 1 | 0 |
Review panels
- Neurology (29)
- Cardiovascular (7)
Most recent Stryker Neurovascular 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K261649 | Excelsior Reach Microcatheter | QJP | 2026-10-09 | 143 |
| K261889 | Trevo Trak 21 Microcatheter | QJP | 2026-07-01 | 26 |
| K253032 | AXS Lift Intracranial Base Catheter | QJP | 2026-02-11 | 142 |
| K252694 | Target Detachable Coil | HCG | 2025-12-11 | 107 |
| K251832 | InZone IST Detachment System; IZDS Connecting Cable | HCG | 2025-10-17 | 123 |
| K242289 | Excelsior XT-27 Microcatheter, Excelsior XT-27 Flex Microcatheter, Excelsior XT-27 Pre-Shaped Microcatheter, Excelsior XT-27 Flex Pre-Shaped Microcatheter | QJP | 2025-03-21 | 231 |
| K243593 | AXS Lift Intracranial Base Catheter | QJP | 2025-02-18 | 90 |
| K241768 | Broadway 8 Catheter | QJP | 2024-12-19 | 182 |
| K241637 | Echo Intracranial Base Catheter | QJP | 2024-12-19 | 195 |
| K223305 | Trevo NXT ProVue Retriever | POL | 2023-03-29 | 153 |
24 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P180031 | PMA | Neuroform Atlas® Stent System | 2019-05-16 |
| P170024 | PMA | Surpass Streamline Flow Diverter | 2018-07-13 |
Recalls
109 product recalls in 23 recall events; 15 initiated in the last five years. Most recent: 2026-04-06.
1 product recall in 1 recall event filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 1 initiated in the last five years. Most often: Stryker, Inc. (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Stryker Neurovascular is the lead sponsor of 23 device studies on ClinicalTrials.gov (4 active or recruiting). Most recent:
- NCT06872684: Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD) (Recruiting, started 2025-06-20)
- NCT06368622: Evolve China PMCF Study (Active not recruiting, started 2024-04-24)
- NCT05544045: China Surpass Streamline Post-Market Study (Terminated, started 2022-06-03)
- NCT04572230: International Post Market Surveillance Study of Intracranial Aneurysms Treated With an Endovascular Approach (Active not recruiting, started 2020-12-21)
- NCT04380350: Trenza Embolization Device for Intrasaccular Aneurysm Treatment (Completed, started 2020-12-17)
Parent company SEC filings
STRYKER CORP (SYK): EDGAR filings, CIK 310764. Caduvo groups Stryker Neurovascular under Stryker; the parent's SEC registrant is entered by hand for the group, not matched by name.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Stryker Corp. (297 510(k)s)
- Stryker Endoscopy (102 510(k)s)
- Stryker Instruments (78 510(k)s)
- Stryker Spine (75 510(k)s)
- Stryker GmbH (55 510(k)s)
- Stryker Sustainability Solutions (34 510(k)s)
- Stryker Trauma AG (25 510(k)s)
- Stryker Orthopaedics (24 510(k)s)
- Stryker Leibinger GmbH & Co KG (22 510(k)s)
- Stryker Medical (14 510(k)s)
- Stryker Leibinger (12 510(k)s)
- Stryker Trauma GmbH (7 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Stryker Neurovascular?
FDA lists 34 510(k) clearances under the applicant name “Stryker Neurovascular” (first 2011, latest 2026), plus 2 PMA decisions, across 9 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Stryker Neurovascular?
The median time from FDA receipt to decision across 510(k)s cleared under the name Stryker Neurovascular is 105 days. Since 2017: 123 days, versus 118 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Stryker Neurovascular?
The most frequent FDA product codes under this applicant name are HCG (Device, Neurovascular Embolization, 11); QJP (Catheter, Percutaneous, Neurovasculature, 10); DQY (Catheter, Percutaneous, 6).
Next steps
- See all 34 Stryker Neurovascular clearances with predicates and recalls
- Run predicate analysis for product code HCG, Stryker Neurovascular's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.